ImpediMed Oncology
ImpediMed Oncology
1 FOLLOWERS
Secondary lymphedema is a leading post-treatment complication for many cancer patients, costing the U.S. healthcare system an estimated $7 billion annually.1 Of the nearly 17 million cancer survivors in the U.S., roughly one in three treated for the cancers below will develop chronic lymphedema.2,3 Lymphedema is a risk for women and men treated with surgery, radiation or Taxane-based..
How To Take a Measurement - Software Version 5.0
ImpediMed Oncology
by ImpediMed Oncology
1M ago
..read more
Visit website
PREVENT Trial Lymphedema Insights Webinar
ImpediMed Oncology
by ImpediMed Oncology
1y ago
..read more
Visit website
Device Effective in Detecting Lymphedema
ImpediMed Oncology
by ImpediMed Oncology
1y ago
..read more
Visit website
Breast Cancer Awareness: How Lymphedema Impacts Survivors
ImpediMed Oncology
by ImpediMed Oncology
1y ago
..read more
Visit website
Non-Invasive Device More Effective for Early Detection of Lymphedema
ImpediMed Oncology
by ImpediMed Oncology
1y ago
..read more
Visit website
Detecting Lymphedema After Breast Cancer
ImpediMed Oncology
by ImpediMed Oncology
1y ago
..read more
Visit website
Device Effective in Detecting Lymphedema
ImpediMed Oncology
by ImpediMed Oncology
1y ago
..read more
Visit website
Breast Cancer Awareness Month: Checking for Early Detection of Lymphedema
ImpediMed Oncology
by ImpediMed Oncology
1y ago
..read more
Visit website
Early Detection of Lymphedema After Breast Cancer: Non-Invasive Device More Effective
ImpediMed Oncology
by ImpediMed Oncology
1y ago
..read more
Visit website
Shared Decision-Making: How to Advocate for Yourself and Others for Better Lymphedema Care
ImpediMed Oncology
by ImpediMed Oncology
1y ago
..read more
Visit website

Follow ImpediMed Oncology on FeedSpot

Continue with Google
Continue with Apple
OR